Wingfield Tom, Baxter Jo, Herwadkar Amit, du Plessis Daniel, Blanchard Tom J, Javier Vilar F, Varma Anoop
Section of Infectious Diseases & Immunity and Wellcome Trust, Imperial College Centre for Global Health Research, Imperial College London Hammersmith Hospital Campus, 150 Du Cane Road, London W12 0NN, UK ; The Monsall Infection Unit, Regional Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK.
The Monsall Infection Unit, Regional Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK.
Case Rep Neurol Med. 2014;2014:164826. doi: 10.1155/2014/164826. Epub 2014 Mar 5.
Background. HIV-positive people starting combined antiretroviral therapy may develop immune reconstitution to latent or treated opportunistic infections. Immune reconstitution to cerebral Cryptococcus is poorly understood and can be fatal. Case Presentation. A 33-year-old Zimbabwean female presented with cryptococcal meningitis and newly diagnosed HIV with a CD4 count of 51 cells/ μ L (4%). She was treated with amphotericin and flucytosine. Combined antiretroviral therapy was started four weeks later and she showed early improvement. However, over the ensuing 18 months, her clinical course was marked by periodic worsening with symptoms resembling cryptococcal meningitis despite having achieved CD4 counts ≥400 cells/ μ L. Although initially treated for relapsing cryptococcal immune reconstitution syndrome, a brain biopsy taken 17 months after initial presentation showed budding Cryptococci. Conclusion. This unusually protracted case highlights the difficulties in differentiating relapsing cryptococcal meningitis from immune reconstitution and raises questions concerning the optimum timing of initiation of combined antiretroviral therapy in such patients.
背景。开始接受联合抗逆转录病毒治疗的艾滋病毒阳性患者可能会出现针对潜伏性或已治疗的机会性感染的免疫重建。对脑隐球菌的免疫重建了解甚少,且可能是致命的。病例报告。一名33岁的津巴布韦女性因隐球菌性脑膜炎和新诊断的艾滋病毒就诊,其CD4细胞计数为51个/μL(4%)。她接受了两性霉素和氟胞嘧啶治疗。四周后开始联合抗逆转录病毒治疗,她早期病情有所改善。然而,在随后的18个月里,尽管她的CD4细胞计数≥400个/μL,但她的临床病程仍以周期性恶化为特征,症状类似于隐球菌性脑膜炎。尽管最初被诊断为复发性隐球菌免疫重建综合征,但在初次就诊17个月后进行的脑活检显示有芽生隐球菌。结论。这个异常迁延的病例凸显了区分复发性隐球菌性脑膜炎和免疫重建的困难,并引发了关于此类患者开始联合抗逆转录病毒治疗的最佳时机的问题。